Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.

Rasetti-Escargueil C, Avril A, Miethe S, Mazuet C, Derman Y, Selby K, Thullier P, Pelat T, Urbain R, Fontayne A, Korkeala H, Sesardic D, Hust M, Popoff MR.

Toxins (Basel). 2017 Oct 2;9(10). pii: E309. doi: 10.3390/toxins9100309. Review.

2.

Characterization of conformers and dimers of antithrombin by capillary electrophoresis-quadrupole-time-of-flight mass spectrometry.

Marie AL, Dominguez-Vega E, Saller F, Plantier JL, Urbain R, Borgel D, Tran NT, Somsen GW, Taverna M.

Anal Chim Acta. 2016 Dec 1;947:58-65. doi: 10.1016/j.aca.2016.10.016. Epub 2016 Oct 14.

PMID:
27846990
3.

Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.

Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, Avril A, Pelat T, Urbain R, Fontayne A, Thullier P, Sesardic D, Lindström M, Hust M, Korkeala H.

Toxins (Basel). 2016 Sep 12;8(9). pii: E257. doi: 10.3390/toxins8090257.

4.

Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.

Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A, Frenzel A, Thullier P, Pelat T, Urbain R, Fontayne A, Sesardic D, Hust M, Popoff MR.

PLoS One. 2016 Aug 25;11(8):e0161446. doi: 10.1371/journal.pone.0161446. eCollection 2016.

5.

Comparison of antioxidant properties of different therapeutic albumin preparations.

Plantier JL, Duretz V, Devos V, Urbain R, Jorieux S.

Biologicals. 2016 Jul;44(4):226-233. doi: 10.1016/j.biologicals.2016.04.002. Epub 2016 May 5.

6.

A capillary zone electrophoresis method to detect conformers and dimers of antithrombin in therapeutic preparations.

Marie AL, Tran NT, Saller F, Abdou YM, Zeau P, Plantier JL, Urbain R, Borgel D, Taverna M.

Electrophoresis. 2016 Jul;37(12):1696-703. doi: 10.1002/elps.201500456. Epub 2016 Apr 5.

PMID:
26989842
7.

Characterization of monoclonal antibodies by a fast and easy liquid chromatography-mass spectrometry time-of-flight analysis on culture supernatant.

Henninot A, Terrier A, Charton J, Urbain R, Fontayne A, Deprez B, Beghyn T.

Anal Biochem. 2015 Dec 15;491:52-4. doi: 10.1016/j.ab.2015.08.006. Epub 2015 Aug 22.

PMID:
26302360
8.

A fast capillary electrophoresis method to assess the binding affinity of recombinant antithrombin toward heparin directly from cell culture supernatants.

Marie AL, Tran NT, Bianchini EP, Saller F, Pautus S, Abache T, Plantier JL, Urbain R, Borgel D, Taverna M.

J Pharm Biomed Anal. 2015;111:64-70. doi: 10.1016/j.jpba.2015.02.042. Epub 2015 Mar 19.

PMID:
25863018
9.

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions.

Monnet C, Jorieux S, Urbain R, Fournier N, Bouayadi K, De Romeuf C, Behrens CK, Fontayne A, Mondon P.

Front Immunol. 2015 Feb 4;6:39. doi: 10.3389/fimmu.2015.00039. eCollection 2015.

10.

The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.

Le Garff-Tavernier M, Herbi L, de Romeuf C, Azar N, Roos-Weil D, Bonnemye P, Urbain R, Leblond V, Merle-Beral H, Vieillard V.

Haematologica. 2015 Apr;100(4):e147-51. doi: 10.3324/haematol.2014.118083. Epub 2014 Dec 31. No abstract available.

11.

Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?

Joubert JM, Gottenberg JE, Paintaud G; participants of round table N2 of Giens XXIX: Augendre-Ferrante Béatrice 4 Cans Christophe 5 Cellier Dominique 6, Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D.

Therapie. 2014 Jul-Aug;69(4):291-302. doi: 10.2515/therapie/2014050. Epub 2014 Aug 8. English, French.

PMID:
25099671
12.

Recherche translationnelle dans les pathologies immuno-inflammatoires : quels défis, quels progrès attendre, pour quelles innovations thérapeutiques ?

Joubert JM, Gottenberg JE, Paintaud G; et les membres de la table ronde N° 2 de Giens XXIX, Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D.

Therapie. 2014 Jul-Aug;69(4):291-6. doi: 10.2515/therapie/2014049. French. No abstract available.

PMID:
27393224
13.

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Monnet C, Jorieux S, Souyris N, Zaki O, Jacquet A, Fournier N, Crozet F, de Romeuf C, Bouayadi K, Urbain R, Behrens CK, Mondon P, Fontayne A.

MAbs. 2014 Mar-Apr;6(2):422-36. doi: 10.4161/mabs.27854. Epub 2014 Jan 15.

14.

Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry for analyzing qualitative and quantitative variations in therapeutic albumin.

Marie AL, Przybylski C, Gonnet F, Daniel R, Urbain R, Chevreux G, Jorieux S, Taverna M.

Anal Chim Acta. 2013 Oct 24;800:103-10. doi: 10.1016/j.aca.2013.09.023. Epub 2013 Sep 14.

PMID:
24120174
15.

Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.

Ben Abdelwahed R, Donnou S, Ouakrim H, Crozet L, Cosette J, Jacquet A, Tourais I, Fournès B, Gillard Bocquet M, Miloudi A, Touitou V, Daussy C, Naud MC, Fridman WH, Sautès-Fridman C, Urbain R, Fisson S.

Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3657-65. doi: 10.1167/iovs.12-10316.

PMID:
23611989
16.

[EMABling antibodies: from feto-maternal allo-immunisation prophylaxis to chronic lymphocytic leukaemia therapy].

Urbain R, Teillaud JL, Prost JF.

Med Sci (Paris). 2009 Dec;25(12):1141-4. doi: 10.1051/medsci/200925121141. Review. French.

Supplemental Content

Loading ...
Support Center